IFCC – EuroMedLab 2019

European Congress of the International Federation of Clinical Chemistry and Laboratory Medicine

Sebia’s booth: n°154


For more infos: IFCC EuroMedLab Barcelona 2019

Sebia Workshop

Tuesday, May 21st - From 14:45 to 15:45 

Room number: 116 - Level 1

“What’s new in Multiple Myeloma diagnosis: from sebia FLC clinical validation to software assisted interpretations of SPE profiles”

Multiple Myeloma is a complex pathology requiring from the diagnosis standpoint different assays, in order to insure an optimal disease management. Sebia being a key actor in Myeloma diagnosis, provides continuously evolving tools responding to the laboratories needs, from results accuracy to expertise and productivity. The aim of this workshop is to present updates on the 2 centerpieces of myeloma diagnosis assays: Serum Protein electrophoresis (SPE) and Free Light Chains (FLC) quantification.


MODERATOR: Joannes (Hans) F.M. JACOBS, Radboud University Medical Center, The Netherlands

"The diagnosis of protein disorders in a decision making-based laboratory department"

  • SPEAKER: Alberto DOLCI - Clinical Pathology Unit, ASST Fatebenefratelli-Sacco, Milan, Italy

"Clinical validation of the new sebia FLC on a population of Multiple Myeloma patients"

  • SPEAKER: Thomas DEJOIE - Biochemical Laboratory, University Hospital of Nantes, France